Psychedelics As Therapeutic Treatments Focus Of New UW-Madison Psychedelics Master’s Degree

"We're particularly interested in training students to enter the growth pharmaceutical industry surrounding the use of these substances, providing them with the tools to understand the data and also to work in an ethical manner and adhere to all the regulatory pieces surrounding the use of these compounds," he said.

Anonymous Survey Researching 5-MeO-DMT Reactivation Experiences

With the popularization of 5-MeO-DMT as a powerful substance for self-exploration and reconnection with the essence of life, side effects such as the now-famous reactivations (flashbacks) have also been revealed.

By |2021-03-28T14:23:51-08:00March 28, 2021|5-MEO-DMT, Articles & News, DMT|0 Comments

FDA May Allow Trials for Algernon’s Psychedelic DMT

Canada-based Algernon announced its clinical program in January based in part on a preclinical study published last year in Experimental Neurology by researchers from Semmelweis University, which showed DMT can promote neurogenesis and neuroplasticity in a rat model of brain ischemia.

The Ultimate Guide to 4-ACO-DMT, Experience, Benefits & Side Effects

4-AcO-DMT (or psilacetin) is a semi-synthetic tryptamine closely related to the psychedelic mushroom molecules psilocin and psilocybin. In fact, 4-AcO-DMT is widely known as “synthetic mushrooms.” Like psilocybin, it appears that the body metabolizes 4-AcO-DMT into psilocin.

By |2021-03-31T12:00:48-08:00March 7, 2021|4-AcO-DMT, 5-MEO-DMT, DMT|0 Comments

Psychedelic Therapy Needs to Confront the Mystical

Many people have a spiritual experience on psychedelics. How they make meaning of it could be influenced by the metaphysical beliefs of their therapists.

Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories

The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.

Could the Federal Government Help Legalize Psychedelics?

Psychedelics are going mainstream. Not only is the US FDA supportive of research, dozens of medical studies are proving such treatments could be helpful, including Johns Hopkins Medicine and New York University. In research to date, psilocybin has been found to help treat mental health issues, such as depression, anxiety, obsessive-compulsive disorder, and PTSD. LSD may be able to help patients with alcohol addiction and other mental disorders. MDMA-assisted therapy could help treat eating disorders, including anorexia and binge eating.

California Would Legalize Possession Of Psychedelics Like LSD, DMT And Psilocybin Under New Senate Bill

Possession of psychedelics such as psilocybin mushrooms, LSD and DMT would be legalized in California under a new Senate bill that was introduced on Wednesday.

Go to Top